639029-52-0

Basic information

• Product Name: (2R)-N2-(2-chloroethyl)-N2-(3-chloropyrazin-2-yl)propane-1,2-diamine
• Synonyms: (2R)-N2; (2R)-N2; 1,2-propanediamine, N2
• CAS NO: 639029-52-0
• Molecular Formula: C₉H₁₃ClN₄*ClH
• Molecular Weight: 249.14
• Mol File: 639029-52-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 352.1°C at 760 mmHg
• Flash Point: 166.8°C
• Density: 1.305g/cm³
• Vapor Pressure: 3.92E-05mmHg at 25°C
• Refractive Index: 1.584
• CAS DataBase Reference: (2R)-N2-(2-chloroethyl)-N2-(3-chloropyrazin-2-yl)propane-1,2-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: (2R)-N2-(2-chloroethyl)-N2-(3-chloropyrazin-2-yl)propane-1,2-diamine(639029-52-0)
• EPA Substance Registry System: (2R)-N2-(2-chloroethyl)-N2-(3-chloropyrazin-2-yl)propane-1,2-diamine(639029-52-0)

Safety Data

• Hazardous Substances Data: 639029-52-0(Hazardous Substances Data)

Usage

General Description

The chemical compound, (2R)-N2-(2-chloroethyl)-N2-(3-chloropyrazin-2-yl)propane-1,2-diamine, is a derivative of propane-1,2-diamine with two substituents attached to the nitrogen atoms. The compound has a 2R stereochemistry and consists of a 2-chloroethyl group on one nitrogen atom and a 3-chloropyrazin-2-yl group on the other nitrogen atom. (2R)-N2-(2-chloroethyl)-N2-(3-chloropyrazin-2-yl)propane-1,2-diamine is likely to have applications in the pharmaceutical industry, particularly in the development of potential drug candidates or as a chemical intermediate in the synthesis of biologically active compounds. Due to its specific structural features, it may exhibit unique chemical and biological properties that make it of interest for further study and potential applications in medicine and related fields.

Upstream product

• 313657-76-0 (R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine 
• 531503-76-1 (R)-1-(3-chloro-2-pyrazinyl)-2-methyl-4-tritylpiperazine 
• 313657-75-9 (3R)-3-Methyl-1-Tritylpiperazine 
• 109-07-9 (RS)-2-methylpiperazine 
• 75336-86-6 (2R)-methylpiperazine 
• 126458-16-0 (R)-2-methylpiperazine, L-tartrate 

Relevant articles and documents

NOVEL PROCESS

The present invention relates to a process for the preparation of compounds which are therapeutically active in the central nervous system. In one aspect, the invention relates to a process for the preparation of compounds of the general formula (I). The invention also relates to (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine, hydrochloride and a process for preparing the same. Another object of the present invention is a compound of the formula (I). Another object of the present invention is a method for the treatment or prophylaxis of a serotonin-related disorder, comprising administering to a subject in need thereof an effective amount of the compound above; as well as the use of said compound to manufacture a medicament for the treatment of a serotonin-related disorder.